Nuzenio

Business Wire Silence

Business Wire Silence news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares - Business WireBusiness Wire · Mon, 10 Aug 2026 20:01:00 GMTSilence posts mid-stage polycythemia vera win, preps for Phase III - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 18:02:18 GMTSilence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Business WireBusiness Wire · Mon, 10 Aug 2026 11:30:00 GMTSilence Therapeutics Reports Second Quarter 2026 Financial and Business Results - Business WireBusiness Wire · Mon, 10 Aug 2026 11:15:00 GMTSilence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera - Business WireBusiness Wire · Sun, 09 Aug 2026 21:00:00 GMT

Timeline

Mon, 10 Aug 2026 20:01:00 GMTSilence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares - Business Wire
Mon, 10 Aug 2026 18:02:18 GMTSilence posts mid-stage polycythemia vera win, preps for Phase III - FirstWord Pharma
Mon, 10 Aug 2026 11:30:00 GMTSilence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Business Wire
Mon, 10 Aug 2026 11:15:00 GMTSilence Therapeutics Reports Second Quarter 2026 Financial and Business Results - Business Wire
Sun, 09 Aug 2026 21:00:00 GMTSilence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Business Wire Silence.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.